A prominent member of this complex is an enhancer of zeste homolog 2 (EZH2), which is overexpressed in various cancer types, including prostate cancer where its elevated levels correlate with disease progression and higher Gleason score [101,102]. The gene discussed is EZH2; the disease is cancer.